Double Standards – Newsweek and Tom Harkin

In American health care debates, few phrases work harder than “follow the science.” It sounds clean, confident, and pleasantly lab-coated. But in practice, the slogan often gets treated like a gym membership in January: everyone praises it, fewer people use it consistently. The discussion around Double Standards – Newsweek and Tom Harkin captures exactly that tension.

The controversy centers on a 2009 moment when two conversations about medicine seemed to be happening in two different universes. In one universe, mainstream physicians were criticized for not following evidence quickly enough. In the other, complementary and alternative medicine was being promoted as something that deserved more freedom, more integration, and less suspicion from the medical establishment. Put those two conversations side by side, and the double standard becomes hard to miss.

This article looks at Newsweek’s critique of doctors, Senator Tom Harkin’s support for integrative medicine, the role of comparative effectiveness research, and the larger question that still matters today: should every health practice be judged by the same scientific rules?

What Does “Double Standards – Newsweek and Tom Harkin” Mean?

The phrase refers to a debate about consistency in medical evidence. In 2009, Newsweek published Sharon Begley’s article “Why Doctors Hate Science,” arguing that many doctors ignored or resisted research that challenged common medical habits. Her examples included unnecessary imaging, regional differences in surgery rates, and the political backlash against comparative effectiveness research.

At nearly the same time, Senator Tom Harkin of Iowa, a longtime supporter of complementary and alternative medicine, chaired a Senate hearing titled “Integrative Care: A Pathway to a Healthier Nation.” Harkin argued that alternative, complementary, and integrative medicine should be a key part of health care reform. He emphasized prevention, patient-centeredness, and the desire to end what he described as discrimination against alternative health practices.

On the surface, both discussions were about improving health care. But the standards being applied looked very different. Mainstream medicine was being told, correctly, to become more evidence-based, more accountable, and more transparent. Alternative medicine, meanwhile, was often framed as needing acceptance, integration, and protection from conventional skepticism. That is where the double standard enters the waiting room, checks in at the front desk, and refuses to fill out the insurance forms.

Newsweek’s Critique: Why Doctors Were Accused of Ignoring Science

Newsweek’s argument was not pulled from thin air. American medicine has long struggled with clinical variation. The same patient with the same condition may receive different treatment depending on the city, hospital system, specialist, or even the local medical culture. Some of those differences are reasonable. Patients are not widgets, and medicine is not a vending machine. But other differences suggest that habits, financial incentives, and professional traditions sometimes outrun evidence.

One major topic in the Newsweek article was comparative effectiveness research, often shortened to CER. CER asks a practical question: among available treatments, which ones work best, for whom, under what circumstances, and at what cost? It is not glamorous. Nobody makes a superhero movie called “Comparative Effectiveness Man: Defender of Sensible Guidelines.” But it matters because patients deserve treatments that are more likely to help than harm.

Begley criticized medical practices that continued despite evidence questioning their usefulness. Her broader point was that doctors, hospitals, pharmaceutical companies, and medical device makers may resist research when it threatens income, autonomy, or professional comfort. That criticism may sound harsh, but the underlying concern is legitimate. Medicine should not keep doing something simply because “that’s how we do it around here.”

The Strength of Newsweek’s Argument

The strongest part of Newsweek’s argument was its defense of evidence over habit. In a health care system as expensive and complicated as America’s, it is not enough for a treatment to feel modern, aggressive, or reassuring. It needs to be tested. A costly scan that does not improve outcomes is not “being thorough”; it may be a very expensive way to make everyone nervous.

Newsweek also correctly highlighted the fearmongering around CER. Critics warned that comparative effectiveness research would lead to government rationing or bureaucrats denying care. While any health policy can be misused, the basic idea of comparing treatments is not sinister. It is common sense wearing a tie.

The Weakness of Newsweek’s Argument

The weaker part was the broad framing. Saying “doctors hate science” makes a memorable headline, but it oversimplifies a complex problem. Many doctors do want to practice evidence-based medicine. The challenge is that evidence changes quickly, guidelines can be messy, patients often have multiple conditions, and real-life care rarely fits perfectly into a study design.

In other words, the problem is not always that doctors hate science. Sometimes the problem is that science arrives in a 90-page PDF while the doctor has 14 minutes, a patient with five medications, and an electronic health record that behaves like it was designed by raccoons with a grant.

Tom Harkin and the Push for Integrative Medicine

Senator Tom Harkin was not a minor figure in health policy. He served in the U.S. Senate for three decades and became known for major work on disability rights, public health, nutrition, and prevention. His support for the Americans with Disabilities Act remains one of his signature achievements. On public health, he often emphasized prevention and wellness rather than simply treating disease after it appears.

Harkin also played a major role in federal support for alternative medicine research. He helped create the Office of Alternative Medicine at the National Institutes of Health in the early 1990s. That office later evolved into the National Center for Complementary and Alternative Medicine, known as NCCAM, and eventually became today’s National Center for Complementary and Integrative Health, or NCCIH.

At the 2009 Senate hearing, Harkin argued that health reform should include integrative care. He promoted coordination, prevention, patient-centeredness, and therapies that he believed could reduce costs and improve outcomes. Those goals sound reasonable. Better nutrition, exercise, smoking cessation, stress reduction, sleep, community support, and preventive care are not fringe ideas. They are mainstream public health with better shoes.

Where the Criticism Begins

The concern was not with prevention itself. Prevention is essential. The concern was whether “integrative medicine” was being used as a large umbrella that could shelter both evidence-based lifestyle care and therapies with weak or unproven claims.

Harkin’s most controversial statement was that one purpose of the federal alternative medicine center was to “investigate and validate” alternative approaches. That word “validate” is the troublemaker. Science does not begin with the mission of validating a favored treatment. It begins by testing whether a claim is true, false, partly true, or too uncertain to recommend. If research is designed to approve rather than investigate, it stops being science and starts becoming a public relations department in a lab coat.

This is the heart of the double standard. Conventional medicine was being told to submit to stricter evidence, comparative research, guidelines, cost-effectiveness analysis, and quality control. Alternative medicine was sometimes defended as though skepticism itself were unfair discrimination. But if a therapy claims to treat pain, improve immunity, reverse disease, or reduce medication use, it should face the same basic question as any drug, device, surgery, or behavioral intervention: does it work, and is it safe?

The Real Issue: Evidence Should Not Have a VIP Entrance

The debate is not “mainstream medicine good, alternative medicine bad.” That is too easy, and easy answers tend to be where nuance goes to take a nap. Mainstream medicine has made mistakes. It has overused procedures, overprescribed medications, tolerated financial conflicts, and sometimes moved slower than evidence demanded. The point is not to protect conventional medicine from criticism. The point is to make the criticism universal.

If a prescription drug needs randomized trials, safety monitoring, dosage standards, adverse event reporting, and post-market scrutiny, then a supplement or alternative therapy making health claims should not get a magical exemption because it is “natural.” Hemlock is natural. Arsenic is natural. A bear is natural, but most people do not invite one to manage their cholesterol.

Likewise, if doctors are criticized for relying on anecdote, alternative practitioners should not be praised for relying on personal testimonials. A testimonial can be emotionally powerful, but it cannot tell us whether a treatment caused the improvement, whether the condition would have improved anyway, whether other treatments were involved, or whether harms were overlooked.

Complementary, Alternative, and Integrative Medicine: Know the Difference

Part of the confusion comes from terminology. These labels are often used together, but they are not identical.

Complementary Medicine

Complementary medicine refers to non-mainstream practices used alongside conventional care. For example, a cancer patient may use meditation to reduce stress while still receiving chemotherapy. If the complementary approach is safe and honestly presented, it may be helpful as supportive care.

Alternative Medicine

Alternative medicine means using a non-mainstream approach instead of conventional treatment. This is where risk rises sharply. Replacing proven treatment for a serious disease with an unproven remedy can delay care and lead to preventable harm.

Integrative Medicine

Integrative medicine aims to combine conventional and complementary approaches in a coordinated way. In theory, this can be valuable when the included practices are evidence-based. In practice, the label can become blurry. It may include excellent lifestyle medicine, but it may also include treatments whose claims are not well supported.

The solution is simple to state and hard to enforce: integrate what is proven, study what is plausible, and reject what fails fair testing.

Why the Double Standard Persists

Double standards survive because they are emotionally comfortable. Conventional medicine is often viewed as powerful, corporate, cold, expensive, and bureaucratic. Alternative medicine is often marketed as personal, natural, gentle, empowering, and holistic. That branding matters. A pill from a pharmaceutical company sounds suspicious. A capsule from a wellness boutique with a leaf on the label sounds friendly, even if both are chemical substances entering the same human liver.

There is also a deep cultural hunger for care that listens. Many patients turn to alternative practitioners because they feel rushed or dismissed in conventional settings. That experience is real and should not be mocked. If patients feel like they are being treated as a chart number with sneakers, the health system has failed them emotionally, even if the prescription is correct.

But poor bedside manner does not make an unproven therapy effective. The warmth of the practitioner and the truth of the claim are separate questions. Good medicine should have both compassion and evidence. Patients should not have to choose between being listened to and being treated with methods that work.

Specific Example: Comparative Effectiveness Research vs. Alternative Medicine

Comparative effectiveness research asks whether one treatment performs better than another in real-world conditions. In mainstream medicine, this can challenge profitable habits. A cheaper older drug may work as well as a newer expensive one. Physical therapy may beat surgery for some conditions. Watchful waiting may be safer than aggressive intervention.

Now apply the same thinking to alternative medicine. Does acupuncture outperform sham acupuncture for a specific condition? Does an herbal supplement beat placebo? Does chiropractic manipulation improve outcomes beyond natural recovery for a given back pain population? Does a detox product remove measurable toxins, or does it mostly remove money from wallets?

Those questions are not hostile. They are necessary. A therapy that works should welcome good testing. A therapy that avoids testing while demanding insurance coverage, institutional respect, and legal protection is asking for privilege, not fairness.

Media Responsibility: Headlines, Heat, and Health Claims

The Newsweek-Harkin contrast also shows how media coverage can sharpen or blur public understanding. A headline like “Why Doctors Hate Science” grabs attention, but it risks turning a systems problem into a personality flaw. Meanwhile, coverage of alternative medicine can drift toward soft-focus storytelling: inspiring patients, ancient traditions, natural healing, and heroic rebels against the medical establishment.

Good health journalism should resist both temptations. It should not portray all doctors as arrogant dinosaurs allergic to evidence. It should not portray every alternative therapy as gentle wisdom suppressed by Big Medicine. The public needs clear explanations of evidence quality, risks, uncertainty, conflicts of interest, and realistic benefits.

Health journalism has a special responsibility because readers may act on what they read. A bad movie review costs someone two hours. A bad health article can cost someone months of delayed treatment.

What a Fair Standard Would Look Like

A fair standard does not ask whether a treatment is conventional, alternative, ancient, modern, natural, synthetic, Eastern, Western, or recommended by someone with excellent lighting on television. It asks better questions.

1. Is There Good Evidence?

Evidence should include well-designed studies, reproducible findings, meaningful outcomes, and honest reporting of negative results. Cherry-picked success stories are not enough.

2. Is It Safe?

Safety does not mean “no one complained in the comment section.” It means known risks, interactions, contraindications, quality control, and adverse event tracking have been taken seriously.

3. Is the Claim Proportionate?

A relaxation practice claiming to reduce stress is one thing. A supplement claiming to cure cancer is another. The bigger the claim, the stronger the evidence must be.

4. Is the Patient Being Fully Informed?

Patients deserve to know what is proven, what is promising, what is uncertain, and what is unsupported. “May support wellness” should not be code for “we hope you do not ask too many questions.”

Experiences and Practical Reflections on the Double Standard

One of the most useful experiences related to the Newsweek and Tom Harkin debate is watching how people react when the same evidence rule is applied to something they already like. If a pharmaceutical company says, “Trust us, our product works because customers love it,” most readers immediately demand clinical trials. Good. That is healthy skepticism. But if a natural health brand says nearly the same thing with softer colors and a photo of a sunrise, skepticism sometimes takes the afternoon off.

In real-world health communication, this pattern appears again and again. People are often suspicious of “chemicals,” forgetting that water is a chemical and so is caffeine, oxygen, and the compound responsible for the smell of fresh-baked bread. They may distrust a prescription drug because it has side effects listed on the label, yet trust an herbal product because the risks are not listed as clearly. Ironically, the long warning label may be a sign of better regulation, not greater danger.

Another practical experience is seeing how strongly personal stories influence belief. If someone says acupuncture helped their migraines, or a supplement improved their fatigue, that story deserves respect. Nobody wants to be the person at the dinner table saying, “Actually, your lived experience lacks adequate blinding.” That is how you stop getting invited to dinner. But respect for the person does not mean automatic acceptance of the conclusion. Symptoms fluctuate. Placebo effects are real. Regression to the mean is real. Lifestyle changes often happen at the same time as alternative treatments. The story can be sincere and still not prove the claim.

Editors and writers covering this topic should treat the double standard as a lesson in intellectual hygiene. Clean thinking requires using the same soap on every claim. If conventional medicine overuses a test, investigate it. If an alternative clinic promises immune boosting without defining what that means, investigate that too. If a hospital markets “integrative” services, ask which parts are evidence-based and which are offered mainly because patients request them. If a supplement company uses vague structure-function claims, ask whether the average consumer is likely to misunderstand them as disease-treatment claims.

For patients, the experience is more personal. The best approach is not cynicism; it is informed curiosity. Ask: What is the evidence? What are the risks? What happens if I do nothing? What are the alternatives? Will this interact with my medication? Is this replacing proven care? A trustworthy clinician should welcome those questions. If someone responds with “science can’t measure this,” “doctors don’t want you to know,” or “there are no side effects because it is natural,” consider that a flashing red light, preferably one with a siren.

The deeper lesson of Double Standards – Newsweek and Tom Harkin is that patients deserve both openness and rigor. Medicine should be open to new ideas, but not so open that its standards fall out. It should value prevention, nutrition, exercise, compassion, and patient-centered care. It should also reject magical thinking, weak claims, and special pleading. The goal is not to defend one tribe of medicine against another. The goal is to protect patients from bad reasoning, whether it arrives in a white coat, a wellness brochure, or a Senate hearing room.

Conclusion: One Standard for Every Health Claim

The debate around Double Standards – Newsweek and Tom Harkin remains relevant because the same issue keeps returning under new names. Evidence-based medicine, comparative effectiveness research, integrative care, lifestyle medicine, supplements, wellness, biohacking, functional healththe labels change, but the central question does not.

Should health claims be tested fairly, or should some claims receive special treatment because they are popular, natural, traditional, profitable, or politically appealing?

The only patient-centered answer is consistency. Conventional medicine should be challenged when it ignores evidence. Alternative medicine should be challenged when it asks for acceptance without proof. Integrative medicine should be welcomed when it integrates compassion, prevention, and treatments supported by reliable science. It should be rejected when it integrates wishful thinking with a billing code.

Science is not perfect, but it is still the best tool we have for separating what helps from what merely sounds hopeful. And in health care, hope is wonderfulbut hope plus evidence is much better. It also tends to come with fewer detox teas.

Note: This article is written as analytical health policy commentary based on publicly documented debates, Senate hearing records, federal health information, and reputable U.S. medical and policy sources. It is intended for educational publishing and should not be read as personal medical advice.